Volume 13, Issue 2 pp. 194-202
REVIEW ARTICLE

Effects of inspiratory muscle training in chronic heart failure patients: A systematic review and meta-analysis

Jing Wu BSN

Jing Wu BSN

Shanghai Jiao Tong University School of Nursing, Shanghai, People's Republic of China

Search for more papers by this author
Li Kuang BSN

Li Kuang BSN

Shanghai Jiao Tong University School of Nursing, Shanghai, People's Republic of China

Search for more papers by this author
Lijuan Fu MBA, RN

Corresponding Author

Lijuan Fu MBA, RN

Department of Cardiothoracic Surgery, Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China

Correspondence Lijuan Fu, Department of Cardiothoracic Surgery, Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine, Dongfang Rd #1678, Pudong, Shanghai 200127, People's Republic of China. Email: [email protected]Search for more papers by this author
First published: 08 February 2018
Citations: 34

Funding information: Shanghai Municipal Education Commission-Gaoyuan Nursing Grant Support, Grant/Award Number: Hlgy1603gj

Jing Wu and Li Kuang contributed equally to this work.

Abstract

Objective

The aim of this study was to evaluate the effects of inspiratory muscle training (IMT) in chronic heart failure (CHF) patients.

Design

We searched MEDLINE, EMBASE, Cochrane Library, CINHAL, and CBMdisc to collect controlled trials on the application of inspiratory muscle training in CHF patients from the establishment of these databases to November 2016. Two reviewers independently screened literature according to the inclusion and exclusion criteria, extracted data, and assessed the quality of literature. Meta-analysis was conducted by software RevMan5.3.

Results

Eight studies involving 302 patients were identified. Meta-analysis indicated that IMT significantly improved PImax, VE/VCO2 slope and dyspnea (weighted mean difference [WMD] = 16.52, 95% CI: 13.87–19.17, P < .01; WMD = –5.78, 95% CI: −7.72 to −3.85, P < .01; SMD = –0.95, 95% CI: −1.5 to −0.39, P < .01), and descriptive results showed that long-term IMT (≥6 weeks) can improve the quality of life of CHF patients, and patients in IMT group also have a significant improvement in 6-minute walking distance test (6-MWD).

Conclusion

IMT can improve pulmonary function, exercise tolerance, and quality of life of CHF patients and relieve the symptom of dyspnea.

CONFLICT OF INTEREST

There is no conflict of interest.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.